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Anticancer properties of chitosan against osteosarcoma, 
breast cancer and cervical cancer cell lines 
 
Abstract 
Background: Cancer is still the most common cause of morbidity in the world. Chitosan, a 
commonly used natural polymer, is consisted of different molecular weight with different 
biological activities.The purpose of this study was to determine cytotoxicity effect of high 
molecular weight (HMWC) and low molecular weight of chitosan (LMWC) on three 
cancerous cell lines MCF-7, HeLa and Saos-2 with different histological origin. 
Methods: The anticancer property of two types of chitosan on three cancerous cell lines 
and human fibroblast as normal cell line, was evaluated by cytotoxic activity including 
their apoptosis induction properties. Chitosan solutions 2% (w/v) were prepared. The cells 
were treated by different concentration of chitosan and viability was determined by MTT 
assay after 24, 48 and 72 h .Also the mode of cell death-apoptosis vs necrosis ,was 
determined by Annexin V staining assay and analyzed by flow cytometry. 
Results: While both types of chitosan were effective in inhibiting cell proliferation of three 
cancerous cell lines, fibroblast cells showed somehow more compatibility with chitosan. 
Despite of a significant decrease in all 3 cell lines viability, up to 90%, but we didn't see a 
concentration dependent difference between both types of chitosan (HMWC and LMWC) 
in their cytotoxic effects. Flow cytometry analysis showed necrosis more observable with 
MCF7 while the apoptosis pattern of death was more in Saos-2 and HeLa. Also, higher 
viability with both types of chitosan was seen in fibroblast as normal cells. 
Conclusion: While chitosan is compatible with normal diploid fibroblast cells, it shows 
anticancerous effect against 3 cancerous cell lines. Furthermore, it seems that the 
molecular weight of chitosan does not affect its anticancerous property. 
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Cancer is still a major public health problem and is one of the most common cause 
of morbidity globally. Shall be inhibited by new anticancer candidates, cell proliferation is 
one of the major steps in cancer cells metastasis of a multistep process that includes cell 
adhesion, invasion, cell proliferation, transport through circulatory system and growth in a 
secondary organ (1, 2). As the consequence of serious adverse reactions of chemotherapy, 
the main purpose of this research is to investigate new anticancer candidate with potential 
low cytotoxicity against normal tissues. Chitosan is one of the natural substances that has 
been used considerably for biomedical applications due to its high biocompatibility, 
biodegradability, low toxicity and intrinsic antibacterial activity (3). Owing these properties, 
chitosan has become excellent candidate for developing new anticancer agent. Chitosan is 
a polysaccharide comprising copolymers of glucoseamine and N-acetylglucosamine (4, 5) and 
can be derived by partial deacetylation of chitin which is naturally present in crab, shrimp, 
shells, lobster, coral, jellyfish, butterfly, ladybug, mushroom, and fungi (6, 7).  
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There are many reports about antitumor activity of 
chitosan in which, its mechanism is related to membrane-
disrupting and apoptosis-inducing activities (8). The 
anticancer properties of chitosan have been postulated by its 
antiproliferative action against human monocytic leukemia 
cell line (THP1) (9) as well as some human breast cancer cell 
lines (10). Necrotic effect was reported in human gastric 
carcinoma cell line MGC803 (11, 12). Qi et al. worked on 
antitumor effect of chitosan on hepatocellular carcinoma and 
showed that antitumor mechanism was mediated by the 
decrease of mitochondrial membrane potential, induction of 
membrane lipid peroxidation and neutralization of cell 
surface charge (13). Takimoto et al. showed that chitosan 
induced apoptosis by modulating death receptor expression 
and activating caspase-8(14). But Hasegawa et al reported 
that chitosan induced apoptotic death of bladder tumor cells 
via caspase-3 activation (15). 
We would like to investigate about anticancer activity of 
the (LMW 100-300 kDa) and HMW 600-800 kDa) chitosan 
using human breast cancer cell line (MCF-7), human 
epithelial cervical cancer (HeLa), osteosarcoma (Saos-2) and 
noncancer fibroblast. Their cytotoxic activity was studied by 
MTT assay, and anticancer activity of apoptosis and necrosis 
were analyzed by flow cytometry. We therefore performed 
the present research to explore the anticancer effects of 
LMWC on cancerous cell lines in comparison with HMWC 
in terms of cytoxicity and apoptosis. 
 
 
Methods 
Materials: The following chemicals and reagents were 
obtained from the companies mentioned below. Chitosan, 
with two different MW: 600-800 kDa and 100-300 kDa with 
deacetylation degree of 75%-85% were purchased (ACROS, 
USA). RPMI 1640 (Gibco, Germany) Trypsin–EDTA 
(Sigma-aldrich), MTT (3-(4, 5-Dimethyl thiazol-2-yl)-2, 5-
Diphenyl tetrazoliumbromide (ACROS, USA), FBS 
(Gibco,), Penicillin/Streptomycin (PAA), DMSO (Sigma-
aldrich,), ApoFlowExFITC kit Exbio (ED7044). 
Cell-Lines: Three different human cell lines: MCF-7 human 
breast cancer), HeLa (human epithelial cervical cancer), 
Saos-2 (osteosarcoma) were purchased from the Pasteur 
Institute of Iran. Cancer cells were grown and maintained in 
Roswell Park Memorial Institute medium (RPMI) 1640 
supplemented with 1% penicillin-streptomycin, 10% (v/v) 
heat-inactivated fetal bovine serum. The cells were 
maintained at 37º C under 5% CO2. The human fibroblast 
cell line was isolated from normal children’s foreskin by 
non- enzymatic method which had been cryopreserved since 
previous project with Ethical code: 
MUBABOL.REC.1390.8. (16). All cell lines were used to 
evaluate the effects of HMWC and LMWC in vitro.  
Preparation of chitosan solution: LMW and HMW chitosan 
were dispersed in a 1% (v/v) glacial acetic acid (Merck, 
Germany) for the preparation of chitosan solutions 2% (w/v) 
and kept stirring at 50

 C overnight for complete dissolution 
of their particles. Then the solutions were autoclaved at 
121

C for 15 min and stored at 4

C until used (17-20). 
Cell cytotoxicity assay: Cell viability assay was carried out 
using the MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide),which measures the activity of 
mitochondrial dehydrogenase in the cells. For cell treatment, 
5*10
3
 cells were seeded into each well of a 96-well flat 
bottom plate (Orange scientific) and the plate was incubated 
at 37°C in a humidified CO2 5%. After 24 h, the cell culture 
medium was replaced by a fresh medium that contained 
HMW and LMW chitosan at final concentrations of 0.25, 
0.5,1,2,4 mg/mL separately. After 24, 48 and 72 h MTT 
solution (5 mg/mL) was freshly prepared and added to each 
well. Three hours after incubation, the formed formazan 
crystals were dissolved in DMSO and the resulting color was 
measured spectrophotometrically using a microplate reader 
(Rayto, China) at a test wavelength of 570 nm and a reference 
wavelength of 630 nm. Each experiment was performed in 
triplicate. Same cell lines without exposure of both types of 
chitosan served as controls. Percentage cell viability was 
calculated by dividing the absorbance of individual wells by 
the mean absorbance of control wells (21, 22). 
Apoptosis by flow cytometry: To determine whether the 
initial cell death occurred in MCF-7, HeLa, Saos-2, and skin 
fibroblast exposed LMW and HMW could be due to 
apoptosis (a programmed cell death), annexin V/PI test was 
carried out. Annexin V is intracellular protein that binds to 
phosphatidylserine (PS). PS is normally only found on the 
intracellular leaflet of the plasma membrane in healthy cells 
but during early apoptosis, membrane is removed and PS 
translocates from inner phospholipid layer to the cell surface. 
Fluorochrome-labeled annexin V can identify apoptotic cells 
and for distinguishing between the necrotic and apoptotic 
cells propidium iodide solution (PI) was used which is a 
fluorescent dye that binds to DNA. The flow cytometry test 
can differentiate early apoptotic cells (FITC+/PI-), late 
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apoptotic cells (FITC-/PI+),necrotic cells (FITC+/PI+) and 
intact cells (FITC-/PI-)(23,24). Annexin V/PI test was 
carried out according to protocol. Briefly, the treated cells 
were harvested by centrifugation and supernatant was 
removed. Washing of pellet was done with cold PBS. Cells 
were resuspended in 100 μL 1 x annexin V binding buffer, 
then.5 μL annexin V and 5 μL PI was added to cell 
suspension. Tubes were incubated in the dark for 15 minutes 
at room temperature. After centrifugation, cells were 
resuspended in 100 μL annexin V binding buffer then were 
analyzed by flow cytometer (PARTEC, Germany). 
Statistical analysis: Statistical analysis was performed using 
SPSS Version 19. The t-test and analysis of variance 
(ANOVA) via Tukey's multiple comparison were used to 
determine the different variable effects on cell lines. The 
difference between numerical results was considered in a 
significant level in p<0.05. 
 
 
Results 
Cell Cytotoxicity assessment: Three cancer cell lines MCF-
7, HeLa, Saos-2 and fibroblast isolated from foreskin were 
treated with a different concentration, (0, 0.25, 0.5, 1, 2, 4 
mg/mL) of LMW and HMW chitosan and cytotoxity was 
measured after 24, 48 and 72 h incubation by MTT assay. 
The morphologic changes were seen in fig 1. 
As shown in figure 2, cytotoxic activity of both types of 
chitosan was concentration-dependent but varied among 
cells tested. With increasing concenteration of HMW and 
LMW chitosan, inhibition rate increased and viability of 
cells significantly decreased. Both types of chitosan were 
more efficient in inhibiting cell proliferation of three cancer 
cell lines than fibroblast as non-cancer cell and cell viability 
reduced concentration-dependently up to 70-90% of the 
control with chitosan to 2 mg/mL in cancer cells (p<0.05). 
The effect of HMW chitosan on Saos and HeLa was more 
than LMW of chitosan because the concentration of 0.5 
mg/mL of HMW chitosan significantly decreased viability of 
cells but LMW chitosan was efficient in 1mg/mL. IC50 
value for HMW chitosan in MCF7, HeLa, and Saos-2 was 
1.68, 1, 1.7, mg/mL and for LMW was 1.76, 1 and 1.63 
mg/mL, respectively.  
Comparision of cytotoxicity between cancer cells and 
fibroblast derived from foreskin  as non-cancer cells showed 
that the viability of dermal fibroblast was higher than cancer 
cells after exposure to HMW and LMW chitosans and both 
types of chitosan have less cytotoxicity on dermal fibroblast 
than cancer cell lines, it means that their side effects are low. 
The effect of HMW and LMW chitosan on all types of 
cell lines was compared to each other and there was no 
significant difference between HMW and LMW chitosan 
(p>0.05) (fig 3). 
Quantification of apoptosis by flow cytometry: Annexin 
V/PI test was carried out for the determination of mode of 
cell death after exposure to 1 and 2 mg/mL of HMW and 
LMW chitosan for 48 h. Apoptotic and necrotic incidence in 
MCF7, Saos-2, HeLa as cancer cell lines and dermal 
fibroblast as normal cell were determined by flow cytometry 
and overall obtained result confirmed the presence of 
apoptosis and necrosis in chitosan-treated cancer cells. The 
apoptotic incidence increased to 34% and 20.46% in Saos-2, 
7.75% and 5.9% in MCF7, 63% and 44.68% in HeLa after 
being treated with 1mg/mL HMW and LMW chitosan, 
respectively.  
The necrotic incidence was 8.46% and 5.98% in Saos-2, 
15.84% and 43.16% in MCF7, 2% and 1.27% in HeLa after 
being treated with 1mg/mL HMW and LMW chitosan, 
respectively. In contrast, fibroblast treated with 1 mg/mL 
HMW and LMW chitosan were like untreated cells and 94% 
to 96% of cells were intact (fig 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Inverted microscopy micrographs of untreated 
cells as control and treated cells with 1mg/mL HMW and 
LMW after 48h .Control cells demonstrated dense cell 
populations, against treated cells. (X 20) 
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Figure 2: Effect of exposure high and low molecular weight chitosan with different concentrations on the viability of MCF7, Saos-2, 
HeLa as cancer cell lines and fibroblast derived from foreskin as non-cancer cell. Apart from fibroblast, the results of MTT assay, 
for each cancer cell lines showed significant differences compare to control (0 concentation of chitosan) (* P<0.05  vs control, 
**P<0.01 vs control, ***P<0.001 vs control). Data represent mean±SEM and experiments performed in triplicate. ns: no significant, 
HMW: High molecular weight, LMW: Low molecular weight. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Comparison of HMW and LMW chitosan on fibroblast (A), HeLa (B), MCF-7 (C) and Saos-2(D), after 48 h 
treatment shows that there is no significant difference between them (P>0.05) except for 4mg/mL on fibroblast and 2 
mg/mL on MCF-7(P<0.01).The results are the means±SEM and experiments performed in triplicate. 
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Figure 4. Determination of the mode of HeLa, Saos-2, MCF7 and fibroblast death using Annexin/ PI staining and 
flowcytometry. The diagram shows the status of the cells after exposure to the two concentrations (1 and 2 mg/mL) of 
HMW and LMW chitosan and implies that chitosan can induce both apoptosis and necrosis in cancer cell lines but 
fibroblast as normal cells was intact . 
 
Discussion 
In this study, chitosan with high (600-800 kDa) and low 
(100-300 kDa) molecular weights were used to compare 
their effects on three cancer cell lines, including MCF-7,  
HeLa, Saos-2 and fibroblast derived foreskin as normal cell. 
The results of MTT assay in the present study, demonstrated 
that HMW and LMW chitosan could exert cytotoxicity 
against MCF-7, Saos-2, and HeLa cell lines and both types 
of chitosan have less cytotoxic properties on dermal 
fibroblast, as a normal cell, than cancerous cell lines. 
Exposure of three cancer cell lines to chitosan showed that 
there is a concentration-dependent decrease in cell 
biomass(with IC50 value from  1 mg/mL up to 1.76 mg/mL. 
after 48 h of treatment)concentration-dependent (fig 2). 
According to the results, there is no significant difference 
between the cytotoxic effects of high and low molecular 
weight chitosan on three cancerous and normal fibroblast 
cell lines except for the concentration of 2 mg/mL on MCF-7  
 
and 4 mg/mL on fibroblast (p<0.01) (fig 3). In contrast to 
our findings, in the previous studies conducted on chitosan 
with different MW, there was a size dependent difference in 
cytotoxicity. However, the chitosan samples used in those 
studies were (chitosan carboxymethyl derivatives (CMCS), 
chitosan thymine conjugate, sulfated chitosan (SCS), 
sulfated benzaldehyde chitosan (SBCS), glycol-chitosan 
(GChi), N-succinyl chitosan (Suc-Chi) conjugates, 
furanoallocolchicinoid chitosan conjugate, Chitosan–metal 
complex and polypyrrole chitosan (25) derivatives of 
chitosan and also their MW were much lower than our 
samples. It also might indicate that from a special range of 
molecular weight, the cytotoxic effects of chitosan are not 
affected by its molecular size and there is no difference. 
The results of flow cytometry analysis implied that the 
action mechanism of chitosan in the three cancer cell lines 
might be different. While apoptosis was the most obvious 
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mode of death in HeLa and Saos-2 cell lines exposed to 
chitosan, necrosis was prevalent in the MCF-7 cell line. It 
seems that chitosan with HMW and LMW induces death in 
each cancer cell line. This finding was also observed with 
both different concentrations of chitosan (Fig 4). 
In a previous study, short-term LMWC exposure, was 
less cytotoxic to HaCaT cells, as normal keratinocyte cells, 
than to Ca9-22 cells as oral squamous cell carcinoma. The 
anticancer activity was exerted through induction of 
apoptosis suggesting that LMWC could be a promising 
natural anticancer agent with fewer side effects on normal 
cells (26). 
The effect of chitosan-copper complex on HeLa and 
293 cell line showed that this complex inhibited tumor cell 
proliferation at 10
3 
mol/L concentration, but not the normal 
human lung fibroblast cell line HLF, similar to our study. 
As a consequence of difference in mechanism of 
cytotoxicity, there are contrary effects of chitosan on the 
cancer cell lines and fibroblast. Cancer cells have greater 
negative charge than normal cells which can be attracted 
more by positive charged amino groups of chitosan (27). 
Chitosan might disrupt the membrane cell through 
electrostatic interaction, leading to secretion of inflammatory 
cytokines, i.e. IL-6 and IL-8. These cytokines are mitogen 
for normal fibroblast but cancer cells might lose their ability 
to respond to the membrane-damaging effects of chitosan, 
including the release of inflammatory cytokines. Chitosan 
might directly attack cancer cells through interaction with 
the tumor cell membrane or extracellularly via a specific 
receptor, or via endocytosis (28, 29).  
Based on Ming Jiang is study, it was found that 24-h 
exposure of MCF-7 cells to 50 μM chitosan derivatives such 
as sulfated chitosan (SCS) and the sulfated benzaldehyde 
chitosan (SBCS) significantly inhibited cell proliferation and 
induced apoptosis. SBCS had better inhibitory effects and a 
lower IC50 compared to SCS, but our study showed necrosis 
was prevalent in the MCF-7 cell line ,it may be the chitosan 
exposure, was 48 h and also only chitosan was used ,not 
chitosan compound (10). 
Antitumor effects of various low molecular weight 
chitosans (21-kDa, 46-kDa, and 120-kDa) and HMW 
chitosan (average 650 kDa), in sarcoma 180–bearing mice 
showed that chitosan with molecular weights of 21 kDa and 
46 Da had antitumor activity while this effect was not 
observed in the mice treated with 130-kDa and 650-kDa 
chitosan (30). 
Moreover human gastric carcinoma MGC803 cell line 
was sensitive to chitosan nanoparticles with an IC50 value of 
3 µg/mL after 48 h treatment (11). The biological effect of 
chitosan on three human melanoma cell lines (not three 
cancer cell lines) was distinctive, the adhesion of primary 
melanoma A375 cell line and proliferation of primary 
melanoma SKMEL28 cell line decreased and induced 
apoptosis in RPMI7951 cell line similar to our study findings 
(31). 
The HMWC cytotoxicity test using MTT assay against 
HepG2, A549, and PC3, as the model tumor cell lines, has 
been carried out before with concentrations ranging from 
0.75 to 50 µg/mL. While HMWC showed significantly 
higher cytotoxicity toward human HepG2 and A549 than 
PC3 cells, in concordance with our study ,those results 
demonstrated that HMWC has antitumor activities against 
various tumor cell lines in vitro and might be applicable as 
an antitumor agent based on the biodegradability and 
biocompatibility of HMWC(32). Galbiati and et al reported 
the chitosan–folate microcapsules loaded with camptothecin 
significantly reduced the proliferation of HeLa tumor cells, 
while they have a negligible effect on fibroblasts (33).  
 In conclusion, two types of chitosan with different 
molecular weights and DDA are implicated to exhibit growth 
inhibitory effects against HeLa, Saos-2 and MCF-7 as tumor 
cell lines. It might be an option for treatment of cancer with 
fewer side effects and more studies involving in vivo 
experiments, drug formulation and clinical trials would be 
necessary in the future. 
 
 
Acknowledgments 
I would like to thank my colleagues from Cellular and 
Molecular Biology Research Center for their contribution. 
 
Funding: This study was financially supported by the 
Research and Technology Council of Babol University of 
Medical Sciences with No: 9542225. 
Conflict of Interest: There is no conflict of interest. 
 
 
References 
1. Shen KT, Chen MH, Chan HY, Jeng JH, Wang YJ. 
Inhibitory effects of chitooligosaccharides on tumor 
growth and metastasis. Food Chem Toxicol 2009; 47: 
1864-71. 
 Caspian J Intern Med 2019; 10(4):439-446  
Anticancer properties of chitosan                                                                       445 
2. Nam KS, Shon YH. Suppression of metastasis of human 
breast cancer cells by chitosan oligosaccharides. J 
Microbiol Biotechnol 2009; 19: 629-33. 
3. Pimenta JA, Zaparolli D, Pécora JD, Cruz-Filho AM. 
Chitosan: effect of a new chelating agent on the 
microhardness of root dentin. Braz Dent J 2012; 23: 212-
7. 
4. Croisier F, Jerome C. Chitosan-based biomaterials for 
tissue engineering. Eur Polym J 2013; 49; 780-92. 
5. Kato Y, Onishi H, Machida Y. Contribution of chitosan 
and its derivatives to cancer chemotherapy. In Vivo 
2005: 19: 301-10. 
6. Venkatesan J, Kim SK. Chitosan composites for bone 
tissue engineering--an overview. Mar Drugs 2010; 8: 
2252-66. 
7. Azuma K, Osaki T, Minami S, Okamoto Y. Anticancer 
and anti-inflammatory properties of chitin and chitosan 
oligosaccharides. J Funct Biomater 2015; 6: 33-49. 
8. Zhang J, Chen XG, Liu CS, Park HJ. Investigation of 
polymeric amphiphilic nanoparticles as antitumor  drug 
carriers. J Mater Sci Mater Med 2009; 20: 991-9. 
9. Salah R, Michaud P, Mati F, et al. Anticancer activity of 
chemically prepared shrimp low molecular weight chitin 
evaluation with the human monocyte leukaemia cell line, 
THP-1. Int J Biol Macromol 2013; 52: 333-9. 
10. Jiang M, Ouyang H, Ruan P, et al. Chitosan derivatives 
inhibit cell proliferation and induce apoptosis in breast 
cancer cells. Anticancer Res 2011; 31: 1321-8. 
11. Qi LF, Xu ZR, Li Y, Jiang X, Han XY. In vitro effects of 
chitosan nanoparticles on proliferation of human gastric 
carcinoma cell line MGC803 cells. World J Gastroenterol 
2005; 11: 5136-41. 
12. Xu Y, Wen Z, Xu Z. Chitosan nanoparticles inhibit the 
growth of human hepatocellular carcinoma xenografts 
through an antiangiogenic mechanism. Anticancer Res 
2009; 29: 5103-9. 
13. Qi L, Xu Z, Chen M. In vitro and in vivo suppression of 
hepatocellular carcinoma growth by chitosan 
nanoparticles. Eur J Cancer 2007; 43: 184-93. 
14. Takimoto H,  Hasegawa M, Yagi K, et al. Proapoptotic 
effect of a dietary supplement: water soluble chitosan 
activates caspase-8 and modulating death receptor 
expression. Drug Metab Pharmacokinet 2004; 19: 76-82. 
15. Hasegawa M, Yagi K, Iwakawa S, Hirai M. Chitosan 
induces apoptosis via caspase-3 activation in bladder 
tumor cells. Jpn J Cancer Res 2001; 92: 459-66. 
16. Abedian Z, Akhavan Niaki H, Zabihi E, et al. 
Spontaneous mesenchymal to epithelial like tissue 
transition (MET) in a long term human skin culture. Int 
Biol Biomed J 2017; 3: 112-18. 
17.  Costa EM, Silva S, Madureira AR, et al. A 
comprehensive study into the impact of a chitosan 
mouthwash upon oral microorganism's biofilm formation 
in vitro. Carbohydr Polym 2014; 101: 1081-6. 
18. Fernandes JC, Tavaria FK, Soares JC, et al. 
Antimicrobial effects of chitosans and 
chitooligosaccharides, upon Staphylococcus aureus and 
Escherichia coli, in food model systems. Food Microbiol 
2008; 25: 922-8. 
19. Busscher HJ, Engels E, Dijkstra RJ, van der Mei HC. 
Influence of a chitosan on oral bacterial adhesion and 
growth in vitro. Eur J Oral Sci 2008; 116: 493-5. 
20. Howling GI, Dettmar PW, Goddard PA, et al. The effect 
of chitin and chitosan on the proliferation of human skin 
fibroblasts and keratinocytes in vitro. Biomaterials 2001; 
22: 2959-66. 
21.  Okamura M, Shimada J, Sakagami H. Comparative 
analysis of cell death induction by cisplatin and 5-FU in 
human oral squamous and hepatocellular carcinoma cell 
lines. Anticancer Res 2008; 28: 253-9. 
22.  Abedian Z, Fattahi S, Pourbagher R, Edrisi S, 
Mostafazadeh A. Sustained small and intermediate size 
proteins expression in phorbol 12-myristate13-
acetate/ionomycine prolonged stimulated human 
fibroblasts. Asian Pac J Trop Biomed 2017; 7: 432-6. 
23. Sagar S, Esau L, Holtermann K, et al. Induction of 
apoptosis in cancer cell lines by the Red Sea brine pool 
bacterial extracts. BMC Complement Altern Med 2013; 
13: 344. 
24. Ranganathan P, Hamad R, Mohamed R, et al. Histone 
deacetylase-mediated silencing of AMWAP expression 
contributes to cisplatin nephrotoxicity. Kidney Int 2016; 
89: 317-26. 
25. Adhikari HS, Yadav PN. Anticancer activity of chitosan, 
chitosan derivatives, and their mechanism of action. Int J 
Biomater 2018; 2018: 2952085. 
26. Wimardhani YS, Suniarti DF, Freisleben HJ, et al. 
Chitosan exerts anticancer activity through induction of 
apoptosis and cell cycle arrest in oral cancer cells. J Oral 
Sci 2014; 56: 119-26. 
 Caspian J Intern Med 2019; 10(4):439-446 
446                                                                             Abedian Z, et al. 
27.  Zhang J, Xia W, Liu P, et al. Chitosan modification and 
pharmaceutical/biomedical applications. Mar Drugs 
2010; 8: 1962-87. 
28.  Wiegand C, Winter D, Hipler UC. Molecular-weight-
dependent toxic effects of chitosans on the human 
keratinocyte cell line HaCaT. Skin Pharmacol Physiol 
2010; 23: 164-70. 
29.  Wimardhani YS, Suniarti DF, Freisleben HJ, Wanandi 
IS, Ikeda MA. Cytotoxic effects of chitosan against oral 
cancer cell lines is molecular-weight dependent and cell-
type-specific. Int J Oral Res 2012; 3: e1. 
30.  Maeda Y, Kimura Y. Antitumor effects of various low-
molecular-weight chitosans are due to increased natural 
killer activity of intestinal intraepithelial lymphocytes in 
sarcoma 180-bearing mice. J Nutr 2004; 134: 945-50. 
31.  Gibot L, Chabaud S, Bouhout S, et al.  Anticancer 
properties of chitosan on human melanoma are cell line 
dependent. Int J Biol Macromol 2015; 72: 370-9. 
32. Park JK, Chung MJ, Choi HN, Park YI. Effects of the 
molecular weight and the degree of deacetylation of 
chitosan oligosaccharides on antitumor activity. Int J Mol 
Sci 2011; 12: 266-77. 
33.  Galbiati A, Tabolacci C, Morozzo Della Rocca B, et al. 
Targeting tumor cells through chitosan-folate modified 
microcapsules loaded with    camptothecin. Bioconjug 
Chem 2011; 22: 1066-72. 
 
